Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy

2011 ◽  
Vol 21 (1) ◽  
pp. 18-25 ◽  
Author(s):  
Ming-Yii Huang ◽  
Meng-Lin Huang ◽  
Ming-Jenn Chen ◽  
Chien-Yu Lu ◽  
Chin-Fan Chen ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Clinical Outcome ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Genetic Polymorphisms ◽  
First Line ◽  
Colorectal Cancer Patients

scholarly journals Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment

2013 ◽  
Vol 8 (1) ◽  
pp. 59-67 ◽  
Author(s):  
J.B. Kjersem ◽  
T. Ikdahl ◽  
O.C. Lingjaerde ◽  
T. Guren ◽  
K.M. Tveit ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Clinical Outcome ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
First Line ◽  
Colorectal Cancer Patients

scholarly journals The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy

2016 ◽  
Vol 5 (7) ◽  
pp. e1188243 ◽  
Author(s):  
Mario Roselli ◽  
Vincenzo Formica ◽  
Vittore Cereda ◽  
Caroline Jochems ◽  
Jacob Richards ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
T Cell ◽  
Clinical Outcome ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
T Cell Subsets ◽  
First Line ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document